Evidence map›Paper›PMID 36851115›Full record

ArticleVaccines2023

The Role of CD1 Gene Polymorphism in the Genetic Susceptibility to Spondyloarthropathies in the Moroccan Population and the Possible Cross-Link with Celiac Disease.

Angelica Canossi, Khadija Oumhani, Tiziana Del Beato, Pierluigi Sebastiani, Alessia Colanardi, Anna Aureli

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Angelica CanossiNational Research Council (CNR), Institute of Translational Pharmacology (IFT), 67100 L'Aquila, Italy.ORCID 0000-0002-2790-905X
Khadija OumhaniLaboratoire d'Immunologie, Institut National d'Hygiene, Rabat 10000, Morocco.
Tiziana Del BeatoNational Research Council (CNR), Institute of Translational Pharmacology (IFT), 67100 L'Aquila, Italy.
Pierluigi SebastianiNational Research Council (CNR), Institute of Translational Pharmacology (IFT), 67100 L'Aquila, Italy.
Alessia ColanardiNational Research Council (CNR), Institute of Translational Pharmacology (IFT), 67100 L'Aquila, Italy.
Anna AureliNational Research Council (CNR), Institute of Translational Pharmacology (IFT), 67100 L'Aquila, Italy.ORCID 0000-0003-3533-4265
Istituto di Farmacologia Traslazionale · ITInstitut National d'Hygiène du Maroc · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spondyloarthropathies (SpA) are a group of chronic inflammatory disorders usually affecting the axial spine and asymmetrical peripheral joints. Strong evidence links genetic and environmental factors to SpA pathogenesis. The HLA-B27 is the most important genetic factor associated with SpA. Nevertheless, the involvement of other HLA and non-HLA loci has been also reported. Some patients with SpA may also manifest features of celiac disease (CeD), thus suggesting a genetic overlap across these autoimmune diseases. Recently, CD1 glycoproteins, a class of molecules able to bind and present non peptidic antigens to T cells, aroused interest for their contribution to the pathogenesis of CeD. Therefore, to evaluate whether functional polymorphisms of CD1A and E genes also influence susceptibility to SpA, we analyzed 86 patients from Morocco affected by SpA and 51 healthy controls, using direct sequencing analysis. An increase of CD1E*01/01 homozygous genotype (

Indexed as

CD1 genesHLA gene polymorphismsIBDsspondyloarthropathy

Identifiers

PMID36851115
PMCPMC9963915
OpenAlexW4317933222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.